25th September 2017
News > Regulatory
22nd August 2017
Wynne-Jones IP – Why an IP strategy is vital to the pharmaceutical industry
An effective intellectual property (IP) strategy is integral to preserving innovation and continuous progression in the pharmaceutical industry.23rd March 2017
Expert Advice from Geldards: General Data Protection Regulations – A game changer for everyone
The Information Commissioner has described it as a “game changer for everyone”. So it probably hasn’t escaped your notice that a new, European wide data protection law is on its way. The General Data Protection Regulation 2016 (“GDPR”) will automatically apply in all EU Member States (without the need for national implementing legislation) from 25th…
01st March 2017
Isansys Lifecare Granted Key Patent for Its Innovative Patient Monitoring Platform
Isansys Lifecare, a digital healthcare company developing an innovative patient monitoring platform which enables the early detection of deterioration in patients, today announces that the European Patent Office has accepted for grant a key method patent. The patent relates to the wireless wearable sensor technology incorporated in the Patient Status Engine (PSE), a CE-marked, Class IIa,…
06th February 2017
Alesi Surgical pioneering surgical device gains United States FDA approval
Alesi Surgical Limited, the leading innovator of minimally invasive surgery technologies has successfully secured FDA (Food and Drug Administration) approval for its Ultravision™ system.13th October 2016
Expert advice from THAY Medical: CE marking usable medical devices
It is now mandatory to show some form of evidence of use safety when CE Marking a medical device. Whether it is a mobile application with a clinical claim, an inhaler or ECG machine - when developing the next iteration or leap in technology or clinic08th August 2016
Investment for The Magstim Company supports growth and expansion
Carmarthenshire-headquartered medical technology developer The Magstim Company has invested in new product development and US expansion after it secured backing from a specialist life sciences, medical and healthcare investor. The company, which makes medical devices used in neuroscience, psychiatry and neurology, secured investment from US firm Telegraph Hill Partners last year. Since then it has developed…
28th July 2016
NHS Wales unites with businesses and universities to move healthcare forward in Wales
MediWales recently delivered the first ever all-Wales NHS collaboration conference, MediWales Connects. The clinically-led event hosted delegates from across the fields of life science, health and care to celebrate research progress and patient-centred working in Wales. The theme of collaboration for clinical progress and innovation illuminated throughout the presentations and paved the way for a…
21st July 2016
United Life Sciences explores the UK life sciences landscape following the EU Referendum outcome: What’s next for UK life sciences?
The UK has voted to leave the European Union (EU). Although this decision has caused political and economic uncertainty for the country, it also presents a new political context with opportunities for a re-energised vision for the UK life sciences sector. United Life Sciences, formed of BIA, Bionow, BioPartner UK, One Nucleus and MediWales, will…
21st July 2016
Geldards: Brexit – Business as usual?
It’s been almost a month now since the UK voted to leave the EU. However, the political turmoil that has followed has meant that we are no further forward in terms of knowing when the UK will give notice to the European Council of its intention to withdraw from the EU, how that will be…